Suppr超能文献

[同期胰肾联合移植中的门静脉和肠道引流]

[Portal venous and enteric drainage in simultaneous pancreas kidney transplantation].

作者信息

Peng Zhi-Hai, Xu Jun-Ming, Fan Yu, Xia Qiang, Chen Guo-Qing, Zhu Zhe-Cheng, Li Ke, Qiu Zheng-Jun, Dai Xue-Ming

机构信息

Department of General Surgery, First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2004 Aug 7;42(15):940-3.

Abstract

OBJECTIVE

To summarize the initial experience of simultaneous pancreas kidney transplantation (SPK) with portal venous and enteric drainage.

METHODS

Between Jane 2001 and Jane 2003, SPK were performed in 5 patients. Systemic venous-enteric drainage (SED) was used in the first 2 patients and portal venous-enteric drainage (PED) in the last 3 cases. All patient were immunosuppressed with quadruple therapy, which included anti-CD25 mAb (Zenapax/Simulect) induction therapy, FK506, mycophenolate mofetil (MMF), and prednisone baseline therapy. The complications were analyzed.

RESULTS

Serum glucose and renal function of the 5 cases were normal and no further insulin was needed within 7 days post-operation. No technique complications such as duodenal fistula and thrombosis were observed, One episode of acute rejection of kidney allograft occurred in one patient with SED, and resolved with a bolus corticosteroids. One case with SED and one with PED were died of sepsis and FK506 toxicity 4 weeks after transplantation. The death occurred with functioning pancreas graft. No latter complications were observed in the 3 survived patients with excellent graft functions.

CONCLUSIONS

Both methods of SED and PED can be performed successfully and with no latter complications. But with its potential physiologic and immunologic advantages, PED might be a standard procedure for SPK.

摘要

目的

总结门静脉和肠道引流式同期胰肾联合移植(SPK)的初步经验。

方法

2001年6月至2003年6月期间,对5例患者实施了SPK。前2例患者采用全身静脉-肠道引流(SED),后3例采用门静脉-肠道引流(PED)。所有患者均接受四联免疫抑制治疗,包括抗CD25单克隆抗体(赛尼哌/舒莱)诱导治疗、FK506、霉酚酸酯(MMF)和泼尼松基础治疗。对并发症进行分析。

结果

5例患者术后7天内血糖和肾功能正常,无需额外胰岛素。未观察到十二指肠瘘和血栓形成等技术并发症。1例接受SED的患者发生1次肾移植急性排斥反应,经大剂量皮质类固醇治疗后缓解。1例接受SED的患者和1例接受PED的患者在移植后4周死于败血症和FK506毒性。死亡发生时胰腺移植物功能良好。3例存活且移植物功能良好的患者未观察到后期并发症。

结论

SED和PED两种方法均能成功实施且无后期并发症。但PED因其潜在的生理和免疫优势,可能成为SPK的标准术式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验